Welcome to the official website of BioCoreUSA Corp!
home > TISSUE ARRAYS > Lung > RLN8010
  • Cores:
    80
    CASES:
    70
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    10
    Tissue Array Type:
    FFPE
    Species:
    Human
RLN8010
$284.00
Add To Collect

Description: Lung cancer tissue array with cancer adjacent tissue, including TNM and clinical stage, 70 cases/80 cores

Details: Lung carcinoma tissue microarray with cancer adjacent tissue, containing 70 cases of adenocarcinoma, with 10 matched cancer adjacent tissue, single core per block

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • Malignant(ⅢA)
  • AT(*)
  • Malignant(IA1)
  • Malignant(IA2)
  • Malignant(IA3)
  • Malignant(ⅡB)
  • Malignant(IB)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • _Ma
TISSUE ARRAYS
RLN8010
1
2
3
4
5
6
7
8
9
10
A
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
B
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
C
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
D
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
E
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
F
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
G
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
H
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
_Ma
RLN8010
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 50 M Lung Adenocarcinoma * T1aN0M0 IA1 Malignant
A2
2 61 F Lung Adenocarcinoma * T1bN0M0 IA2 Malignant
A3
3 63 M Lung Adenocarcinoma * T1bN0M0 IA2 Malignant
A4
4 62 M Lung Adenocarcinoma * T1cN0M0 IA3 Malignant
A5
5 63 M Lung Adenocarcinoma * T1cN0M0 IA3 Malignant
A6
6 62 M Lung Adenocarcinoma * T1cN0M0 IA3 Malignant
A7
7 75 M Lung Adenocarcinoma * T2aN0M0 IB Malignant
A8
8 65 F Lung Adenocarcinoma * T2aN0M0 IB Malignant
A9
9 66 F Lung Adenocarcinoma * T2aN0M0 IB Malignant
A10
10 70 M Lung Adenocarcinoma * T2aN0M0 IB Malignant
B1
11 44 F Lung Adenocarcinoma * T2aN0M0 IB Malignant
B2
12 61 M Lung Adenocarcinoma * T2aN0M0 IB Malignant
B3
13 68 M Lung Adenocarcinoma * T2aN0M0 IB Malignant
B4
14 49 F Lung Adenocarcinoma * T2bN0M0 IIA Malignant
B5
15 76 F Lung Adenocarcinoma (sparse) * T2bN0M0 IIA Malignant
B6
16 69 M Lung Adenocarcinoma * T2bN0M0 IIA Malignant
B7
17 58 M Lung Adenocarcinoma (sparse) * T2bN0M0 IIA Malignant
B8
18 56 F Lung Adenocarcinoma * T2bN0M0 IIA Malignant
B9
19 63 M Lung Adenocarcinoma * T2bN0M0 IIA Malignant
B10
20 58 F Lung Adenocarcinoma with necrosis * T2bN0M0 IIA Malignant
C1
21 55 M Lung Adenocarcinoma * T2bN0M0 IIA Malignant
C2
22 69 F Lung Adenocarcinoma * T2bN0M0 IIA Malignant
C3
23 61 M Lung Adenocarcinoma * T2bN0M0 IIA Malignant
C4
24 69 M Lung Adenocarcinoma * T2bN0M0 IIA Malignant
C5
25 64 M Lung Adenocarcinoma * T3N0M0 IIB Malignant
C6
26 74 M Lung Adenocarcinoma * T2bN1M0 IIB Malignant
C7
27 51 F Lung Adenocarcinoma * T2bN1M0 IIB Malignant
C8
28 42 M Lung Adenocarcinoma * T3N0M0 IIB Malignant
C9
29 69 M Lung Adenocarcinoma with necrosis * T3N0M0 IIB Malignant
C10
30 80 M Lung Adenocarcinoma * T2aN1M0 IIB Malignant
D1
31 52 F Lung Adenocarcinoma * T3N0M0 IIB Malignant
D2
32 59 F Lung Adenocarcinoma * T2bN1M0 IIB Malignant
D3
33 59 M Lung Adenocarcinoma * T2N1M0 IIB Malignant
D4
34 39 F Lung Adenocarcinoma * T2bN1M0 IIB Malignant
D5
35 54 M Lung Adenocarcinoma * T3N0M0 IIB Malignant
D6
36 70 F Lung Adenocarcinoma * T2bN1M0 ⅡB Malignant
D7
37 54 M Lung Adenocarcinoma (sparse) * T3N0M0 IIB Malignant
D8
38 27 M Lung Adenocarcinoma * T2N1MO ⅡB Malignant
D9
39 55 F Lung Adenocarcinoma * T3N0M0 IIB Malignant
D10
40 63 M Lung Adenocarcinoma * T3N0M0 IIB Malignant
E1
41 67 M Lung Adenocarcinoma * T2bN1M0 IIB Malignant
E2
42 50 F Lung Adenocarcinoma * T3N0M0 IIB Malignant
E3
43 68 F Lung Adenocarcinoma * T3N1M0 ⅢA Malignant
E4
44 65 M Lung Adenocarcinoma * T2bN2M0 IIIA Malignant
E5
45 58 F Lung Adenocarcinoma * T3N1M0 IIIA Malignant
E6
46 81 M Lung Adenocarcinoma * T1bN2M0 IIIA Malignant
E7
47 68 F Lung Adenocarcinoma * T2bN2M0 IIIA Malignant
E8
48 68 M Lung Adenocarcinoma * T2bN2M0 IIIA Malignant
E9
49 71 M Lung Adenocarcinoma * T1bN2M0 IIIA Malignant
E10
50 71 M Lung Adenocarcinoma * T4N1M0 ⅢA Malignant
F1
51 64 M Lung Adenocarcinoma * T4N1M0 IIIA Malignant
F2
52 52 M Lung Adenocarcinoma * T2aN2M0 IIIA Malignant
F3
53 55 F Lung Adenocarcinoma * T2bN2M0 IIIA Malignant
F4
54 64 F Lung Adenocarcinoma * T2bN2M0 IIIA Malignant
F5
55 42 M Lung Adenocarcinoma (sparse) * T2aN2M0 IIIA Malignant
F6
56 50 M Lung Adenocarcinoma * T2N2M0 IIIA Malignant
F7
57 62 M Lung Adenocarcinoma * T3N1M0 IIIA Malignant
F8
58 66 F Lung Adenocarcinoma * T3N1M0 IIIA Malignant
F9
59 71 M Lung Adenocarcinoma * T3N1M0 IIIA Malignant
F10
60 58 M Lung Adenocarcinoma * T3N1M0 IIIA Malignant
G1
61 65 F Lung Adenocarcinoma * T3N1M0 IIIA Malignant
G2
62 55 F Lung Adenocarcinoma (sparse) * T2aN2M0 IIIA Malignant
G3
63 64 M Lung Adenocarcinoma * T4N0M0 IIIA Malignant
G4
64 59 M Lung Adenocarcinoma * T3N2M0 IIIB Malignant
G5
65 60 M Lung Adenocarcinoma * T3N2M0 IIIB Malignant
G6
66 62 M Lung Adenocarcinoma * T2bN3M0 IIIB Malignant
G7
67 51 F Lung Adenocarcinoma * T4N2M0 IIIB Malignant
G8
68 57 M Lung Adenocarcinoma * T3N2M0 IIIB Malignant
G9
69 61 M Lung Adenocarcinoma * T3N2M0 IIIB Malignant
G10
70 44 M Lung Adenocarcinoma * T4N2M0 IIIB Malignant
H1
71 65 F Lung Cancer adjacent lung tissue of No.08 * * * AT
H2
72 44 F Lung Cancer adjacent lung tissue of No.11 * * * AT
H3
73 74 M Lung Cancer adjacent lung tissue of No.26 * * * AT
H4
74 69 M Lung Cancer adjacent lung tissue of No.29 * * * AT
H5
75 59 F Lung Cancer adjacent lung tissue of No.32 * * * AT
H6
76 39 F Lung Cancer adjacent lung tissue of No.34 * * * AT
H7
77 54 M Lung Cancer adjacent lung tissue of No.35 * * * AT
H8
78 68 F Lung Cancer adjacent lung tissue of No.43 * * * AT
H9
79 81 M Lung Cancer adjacent lung tissue of No.46 * * * AT
H10
80 51 F Lung Cancer adjacent lung tissue of No.67 * * * AT
_Marker_
Find overlapping cases with this tissue array:
  • RLN8010
    File Format: .xlsx
    Release Date: 2025-01-21 14:38:01
    Download
1.389141s